semaglutide and tirzepatide side effects vs Why You Might Tolerate One

Tirzepatide is the established option with FDA approval, extensive clinical trial data, and growing real-world evidence supporting its efficacy in both type 2 diabetes and obesity

Insist on response date

Sulfation (Safe Pathway) DECREASES 33% The Brookhuis 2021 data showed: The estimated molar dose fraction of acetaminophen-sulphate decreased with the duration of pregnancy (24.2 (22.326.2%), 21.5 (19.923.1%) and 20.7 (19.122.4%) in the first, second and third trimester, respectively) compared with non-pregnant women (31.1 (29.033.3%)).[] **This is a 33% DECREASE in the safe sulfation pathway by third trimester** (20.7% vs 31.1%)

Talk with a qualified healthcare provider before starting a protocol